A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09
- 1 November 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 51 (3) , 85-86
- https://doi.org/10.1016/s0360-3016(01)01981-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: